Sparlon User Fee Date Extended To August
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA has extended the user fee date for Cephalon's attention deficit/hyperactivity disorder treatment Sparlon (modafinil) to Aug. 22, the company said April 24